Protein Structure Prediction
Amino acid sequences and structural data predict 3D protein folding to accelerate drug design and novel protein creation.
Business impact
- Prediction accuracy — Higher accuracy reduces experimental validation time and increases confidence in models
- Drug discovery speed — Faster protein structure predictions shorten drug design cycles and time to market
- Designer proteins created — Enables creation of novel proteins with specific functions for biotech and therapeutics
Data requirements
- Amino acid sequences (Text) — Primary input data for predicting 3D protein folding and structure
- Known protein structures databases (Structured) — Used as training and reference data for AI model learning and validation
- Experimental structural data (X-ray, NMR, cryo-EM) (Image) — Benchmark and validate predicted protein structures against empirical measurements
AI methods and techniques
- Predictive AI — Models forecast protein folding and 3D conformations from sequence data
- Generative AI — Generates novel amino acid sequences predicted to fold into desired structures
- Agentic AI — Automates iterative design and optimization of protein structures in silico
- Symbolic AI — Incorporates physics-based rules and constraints to refine predictions
AI models and model families
AlphaFold 2, AlphaFold 3, Rosetta, ESM-2, NSP3 neural network, Variational Quantum Eigensolver
Industries
Real-world evidence
6 documented case studies on record.
Companies using this: Alchemab Therapeutics, Institute for Protein Design, Isomorphic Labs, LG AI Research, Nuclera, University of Washington.
View the full profile with evidence, implementation detail, and comparison tools
Explore full use case →
Explore full use case →